Compositions and methods for treating spinal muscular atrophy
AssigneeAcceleron Pharma Inc.
InventorsRavindra Kumar, Naga Venkata Sai Rajasekhar Suragani, Jia Li
Life of this patent
Estimating the term…
Abstract
In certain aspects, the disclosure provides compositions and methods for treating spinal muscular atrophy. For example, in some embodiments, the disclosure provides ALK4:ActRIIB antagonists that may be used to treat spinal muscular atrophy, particularly treating one or more complications of spinal muscular atrophy including, for example, increasing muscle mass muscle strength, and bone mineral density.
Claims32
A method of treating spinal muscular atrophy (SMA) in a patient, comprising administering to a patient in need thereof an effective amount of an ALK4:ActRIIB antagonist.
The method of any preceding claim, wherein patient has SMA3.
The method of any preceding claim, wherein the method increases bone mineral density in the patient.
The method of any preceding claim, wherein the method increases muscle mass in the patient.
The method of any preceding claim, wherein the method increases muscle strength in the patient.
The method of any preceding claim, wherein the method results in improvement in motor milestones according to Section 2 of the Hammersmith Infant Neurologic Exam (HINE).
The method of any of the preceding claims, wherein the method further comprises administration of an additional active agent or supportive therapy for treating SMA.
The method of any preceding claim, wherein the ALK4:ActRIIB antagonists is a recombinant ALK4:ActRIIB heteromultimer.
Dependencies are inferred from the claim text.